U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 3
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
- --------------------------------------------------------------------------------
1. Name and Address of Reporting Person*
Rosenwald, M.D., Lindsay A.
- --------------------------------------------------------------------------------
(Last) (First) (Middle)
787 Seventh Avenue, 48th Floor
- --------------------------------------------------------------------------------
(Street)
New York, New York 10019
- --------------------------------------------------------------------------------
(City) (State) (Zip)
- --------------------------------------------------------------------------------
2. Date of Event Requiring Statement (Month/Day/Year)
1/25/2000
- --------------------------------------------------------------------------------
3. IRS Identification Number of Reporting Person, if an entity (Voluntary)
- --------------------------------------------------------------------------------
4. Issuer Name and Ticker or Trading Symbol
Urogen Corp. (UROG)
- --------------------------------------------------------------------------------
5. Relationship of Reporting Person to Issuer
(Check all applicable)
|_| Director |X| 10% Owner
|_| Officer (give title below) |_| Other (specify below)
- --------------------------------------------------------------------------------
6. If Amendment, Date of Original (Month/Day/Year)
- --------------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check applicable line)
|_| Form filed by One Reporting Person
|_| Form filed by More than One Reporting Person
================================================================================
- --------------------------------------------------------------------------------
Table I -- Non-Derivative Securities Beneficially Owned
- --------------------------------------------------------------------------------
<TABLE>
<CAPTION>
3. Ownership Form:
2. Amount of Securities Direct (D) or
1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership
(Instr. 4) (Instr. 4) (Instr. 5) (Instr. 5)
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
Common Stock 91,225 D
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 1,704,706 I By The Aries Master Fund(1)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 773,616 I By Aries Domestic Fund, L.P.(1)
- ------------------------------------------------------------------------------------------------------------------------------------
Common Stock 120,315 I By Aries Domestic Fund II, L.P.(1)
- ------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
* If the Form is filed by more than one Reporting Person see instruction
5(b)(v).
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
Page 1 of 3
<PAGE>
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<TABLE>
<CAPTION>
- ------------------------------------------------------------------------------------------------------------------------------------
5. Ownership
3. Title and 4. form of
Amount of Conversion Derivative
2. Date Securities or Security:
Exercisable and Underlying Exercise Direct (D)
1. Title of Derivative Expiration Date Derivative Price of or Indirect 6. Nature of Indirect
Security (Month/Day/ Security Derivative (I) (Instr. Beneficial Ownership
(Instr. 4) Year) (Instr. 4) Security 5) (Instr. 5)
--------------------------------------------
Amount
Date Expir- Title or
Exerci- ation Date Number
sable of Shares
- ------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Warrant 1/25/2000 1/25/2005 Common 33,113 $0.75 D
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant 1/25/2000 1/25/2005 Common 374,703 $0.75 I By The Aries Master Fund(1)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant 1/25/2000 1/25/2005 Common 170,045 $0.75 I By Aries Domestic Fund, L.P.(1)
- ------------------------------------------------------------------------------------------------------------------------------------
Warrant 1/25/2000 1/25/2005 Common 26,446 $0.75 I By Aries Domestic Fund, L.P.(1)
- ------------------------------------------------------------------------------------------------------------------------------------
</TABLE>
Explanation of Responses:
(1) See Attachment A
/s/ Lindsay Rosenwald February 3, 2000
- ---------------------------- ----------------
**Lindsay A. Rosenwald, M.D. Date
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, See Instruction 6 for procedure.
Page 2 of 3
<PAGE>
ATTACHMENT A
Reporting Person: Lindsay A. Rosenwald, M.D.
Issuer: Urogen Corp.
Statement For: January 2000
Paramount Capital Asset Management, Inc. ("PCAM") is the general partner of each
of Aries Domestic Fund, L.P. ("Aries I") and Aries Domestic Fund II, L.P. (Aries
II) and also serves as the investment manager of the The Aries Master Fund
("Master Fund"). Dr. Rosenwald is the chairman and sole stockholder of PCAM. As
a result, Dr. Rosenwald and PCAM may be deemed to have voting and investment
control over the securities of the issuer owned by the Aries Funds under Rule
16a-(a)(1) of the Securities Exchange Act of 1934. Dr. Rosenwald and PCAM
disclaim beneficial ownership of the securities held by the Aries Funds, except
to the extent of its pecuniary interest therein, if any.
Page 3 of 3
